株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

セリアック病(CD) - 疫学的予測

Celiac Disease- Epidemiology Forecast to 2028

発行 DelveInsight Business Research LLP 商品コード 524424
出版日 ページ情報 英文 50 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.49円で換算しております。
セリアック病(CD) - 疫学的予測 Celiac Disease- Epidemiology Forecast to 2028
出版日: 2019年01月01日 ページ情報: 英文 50 Pages
概要

主要7カ国(米国、英国、ドイツ、フランス、イタリア、スペイン、日本)におけるセリアック病(CD)の総有病数は2016年に402万7,782人と見積もられています。

当レポートでは、セリアック病について調査し、疾病の概要、患者背景、主要7カ国の有病数・罹患数の動向(過去3年間・今後10年間分)、疫学的予測、成長要因および市場の障壁、今後の市場機会などを包括的にまとめています。

目次

第1章 レポートの概要

第2章 疾病背景と概要

  • イントロダクション
  • セリアック病の種類
  • 原因
  • 症状
  • 発症機序
    • 難治性セリアック病(RCD)I型
    • 難治性セリアック病(RCD)II型
  • 診断
    • 米国消化器病学会:推奨ガイドライン
    • 英国消化器病学会:成人セリアック病の診断のためのガイドライン

第3章 疫学と患者人口

  • 主な所見
  • 人口と予測パラメーター
  • 米国
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数
  • ドイツ
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数
  • フランス
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数
  • スペイン
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数
  • イタリア
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数
  • 英国
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数
  • 日本
    • セリアック病の有病数
    • セリアック病の罹患数
    • 治療可能な症例数

第4章 付録

第5章 調査手法

第6章 コンサルティングサービス

第7章 免責事項

第8章 DelveInsightについて

図表

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Celiac Disease in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Celiac Disease in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Celiac Disease in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Celiac Disease in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Celiac Disease in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Celiac Disease in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Celiac Disease in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Celiac Disease in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Celiac Disease in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Celiac Disease in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Celiac Disease in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Celiac Disease in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Celiac Disease in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Celiac Disease in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Celiac Disease in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Celiac Disease in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Celiac Disease in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Celiac Disease in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Celiac Disease in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Celiac Disease in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Celiac Disease in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Celiac Disease in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Celiac Disease in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Celiac Disease in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Celiac Disease in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Celiac Disease in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Celiac Disease in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Celiac Disease in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Celiac Disease in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Celiac Disease in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Celiac Disease in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Celiac Disease in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Celiac Disease in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Celiac Disease in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Celiac Disease in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Celiac Disease in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Celiac Disease in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Celiac Disease in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Celiac Disease in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Celiac Disease in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Celiac Disease in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Celiac Disease in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Celiac Disease in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Celiac Disease in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Celiac Disease in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Celiac Disease in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Celiac Disease in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Celiac Disease in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Celiac Disease in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Celiac Disease in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Celiac Disease in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Celiac Disease in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Celiac Disease in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Celiac Disease in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Celiac Disease in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Celiac Disease in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Celiac Disease in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Celiac Disease in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Celiac Disease in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Celiac Disease in Japan (2016-2028)
目次
Product Code: DIEI0008

DelveInsight's "Celiac Disease - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Celiac Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Celiac Disease Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Celiac Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Celiac Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Celiac Disease scenario.

Celiac Disease Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Celiac Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Celiac Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Celiac Disease Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Celiac Disease

Key assessments

  • Patient Segmentation in Celiac Disease
  • Celiac Disease Risk & Burden
  • Factors driving growth in a specific Celiac Disease patient population

Table of Contents

1. Report Introduction

2. Celiac Disease Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Celiac Disease in 2016
  • 2.2. Patient Share Distribution of Celiac Disease in 2028

3. Disease Background and Overview: Celiac Disease

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Celiac Disease in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Celiac Disease in 7MM - By Countries

5. Epidemiology of Celiac Disease by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.1.3. Sub-Type Specific cases of the Celiac Disease *
    • 5.1.4. Sex- Specific Cases of the Celiac Disease*
    • 5.1.5. Diagnosed Cases of the Celiac Disease
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.4.3. Sub-Type Specific cases of the Celiac Disease*
    • 5.4.4. Sex- Specific Cases of the Celiac Disease*
    • 5.4.5. Diagnosed Cases of the Celiac Disease
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.5.3. Sub-Type Specific cases of the Celiac Disease*
    • 5.5.4. Sex- Specific Cases of the Celiac Disease*
    • 5.5.5. Diagnosed Cases of the Celiac Disease
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.6.3. Sub-Type Specific cases of the Celiac Disease*
    • 5.6.4. Sex- Specific Cases of the Celiac Disease*
    • 5.6.5. Diagnosed Cases of the Celiac Disease
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.7.3. Sub-Type Specific cases of the Celiac Disease*
    • 5.7.4. Sex- Specific Cases of the Celiac Disease*
    • 5.7.5. Diagnosed Cases of the Celiac Disease
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.8.3. Sub-Type Specific cases of the Celiac Disease*
    • 5.8.4. Sex- Specific Cases of the Celiac Disease*
    • 5.8.5. Diagnosed Cases of the Celiac Disease
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Celiac Disease
    • 5.9.3. Sub-Type Specific cases of the Celiac Disease*
    • 5.9.4. Sex- Specific Cases of the Celiac Disease*
    • 5.9.5. Diagnosed Cases of the Celiac Disease

6. Unmet Needs of the Celiac Disease

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific